Merck & Co
AstraZeneca and Merck in $8.5-billion oncology deal
27 July 2017
Merck calls off late-stage trial of Alzheimer’s drug verubecestat
15 February 2017
Merck wins $2.54 bn in royalties in patent lawsuit
16 December 2016
Merck & Co among five pharmaceutical companies in the race for Medivation
18 August 2016
Merck & Co and Allergan eye US biotechnology company Biogen
03 August 2016
Merck gets a $5-mn Ebola vaccine shot from Vaccine Alliance
22 January 2016
EU conditional nod for Merck's $17-bn purchase of Sigma-Aldrich
16 June 2015
Merck & Co to buy Cubist Pharmaceuticals for $8.4 bn
10 December 2014
Merck & Co in talks to buy Cubist Pharmaceuticals for more than $7 bn
06 December 2014
Merck oncology drug wins ‘breakthrough’ classification by US regulators
28 October 2014
Merck & Co to sell some eye care products to Japan’s Santen Pharmaceutical for $600 mn
13 May 2014
Merck & Co to sell consumer care business to Germany's Bayer for $14.2 bn
06 May 2014
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 April 2014
Bayer, Novartis, Reckitt Benckiser, P&G in fray for Merck & Co's consumer healthcare unit
20 February 2014
Merck & Co agrees to pay $100 mn to settle NuvaRing contraceptive lawsuits
08 February 2014
Merck & Co mulls sale of consumer healthcare, animal health businessess
01 February 2014
Aspen Pharmacare to buy API business from Merck in $1 billion deal
27 June 2013
Merck & Co to buy back $5-bn worth stock
22 May 2013
Delhi HC refuses interim relief to Merck over Glenmark drug
05 April 2013
Merck to pay $688 mn to settle anti-cholesterol drug Vytorin lawsuits
15 February 2013
Merck & Co forecast profit decline for 2013
02 February 2013
Merck to recall good HDL cholesterol drug Tredaptive
12 January 2013
Merck & Co in talks to buy Bangalore-based Micro Labs: report
21 June 2012
China sales, Singulair drive Merck’s Q1-2012 net to $3 bn
28 April 2012
Merck, Brazil’s Supera Farma to form JV for generic drugs
16 February 2012
Merck to pay $950 million to settle Vioxx drug charges
24 November 2011
Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million
29 September 2011
Merck & Co to axe 13,000 more jobs by 2015
30 July 2011
Sun to co market Merck's Diabetes drugs in India
25 April 2011
Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US
23 April 2011
Merck, Sun Pharma in generics JV
11 April 2011
Merck hopes to be among top-five drugmakers in India
11 March 2011
Merck and Ranbaxy end drug development pact
06 January 2011
Merck to buy diabetes drug developer SmartCells in a $500 million-plus deal
03 December 2010
Merck aims for top slots in seven emerging markets
15 November 2010
Merck enters drug distribution pact with South Africa's Adcock Ingram
24 June 2010
Merck settles Zetia patent suit with Glenmark
11 May 2010
Battelle, IBM, Merck join UPMC’s effort to produce vaccines
12 March 2010
Merck receives EC approval for infertility treatment drug Elnova
28 January 2010
Former CDC chief Dr. Julie Gerberding appointed president of Merck Vaccines
22 December 2009
Merck wins summary judgment in Vioxx lawsuit in Texas
23 November 2009
Merck receives FDA approval for new fertility drug for women
21 November 2009
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
30 October 2009
Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies
29 September 2009
Merck, Wellcome Trust tie up to make affordable drugs in India
19 September 2009
Judge declares mistrial in Merck's Fosamax case
12 September 2009
Merck wins court ruling on Singulair patent
20 August 2009
Merck, Schering-Plough shareholders approve $41-billion deal
10 August 2009
Merck’s Q2 profit falls, but beats expectations
22 July 2009
Merck, Schering-Plough settle Vyotorin dispute with states
16 July 2009
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
Merck plans buy-back of 35 per cent equity at Rs435 a share
20 May 2009
Pharma majors under merger pressure after Merck-Schering deal
12 March 2009
Merck to acquire Schering- Plough for $41 billion
09 March 2009
Merck launches division for follow-on biotech drugs
11 December 2008
FDA bars use of Merck's cancer vaccine by women over 27
26 June 2008
Ranbaxy to develop new drugs for Merck & Co
10 May 2008
Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants
03 May 2008
US FDA turns down Merck's ER niacin / laropiprant
29 April 2008
Shasun Chemicals technology licenses API technology to Merck
27 February 2008
Nicholas Piramal in R&D collaboration with Merck & Co
19 November 2007
Merck agrees to settle Vioxx claims for $4.85 billion
15 November 2007
Merck buys cardiac biotech start-up NovaCardia
31 July 2007
Merck to acquire NovaCardia for $350 million
27 July 2007
Court revives shareholder lawsuits over Vioxx against Merck
20 July 2007
Ranbaxy withdraws bid for Merck's generic business
20 March 2007
Ranbaxy enters second round of bidding for Merck unit: report
16 March 2007
Merck suffers adverse Vioxx lawsuit in the US
13 March 2007
Dr Reddy's to join the race for Merck's generic business
05 February 2007
Ranbaxy to bid over $5 billion for Merck Generics
09 January 2007
Tata Group''s Advinus to develop metabolic drugs for Merck
16 November 2006
Merck & Co develops new diabetes drug
14 June 2006
Merck wins second Vioxx lawsuit
18 February 2006
Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs
02 February 2006
Dr Reddy's Laboratories enters into agreement with Merck
01 February 2006
Merck, ICMR to conduct joint trials on cervical cancer vaccine
22 December 2005
Merck antifungal drug faces key U.S. panel test
16 February 2001
 search domain-b
  go